NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,524,034 | $12,832,000 | 7.64% |
| Healthcare Value Capital, LLC | 831,440 | $7,001,000 | 7.50% |
| ARMISTICE CAPITAL, LLC | 1,420,000 | $11,956,000 | 2.83% |
| Sarissa Capital Management LP | 1,025,000 | $8,630,000 | 2.38% |
| Broadfin Capital, LLC | 1,948,554 | $16,407,000 | 1.82% |
| JW Asset Management, LLC | 324,280 | $2,731,000 | 1.82% |
| Tiger Legatus Capital Management, LLC | 320,000 | $2,694,000 | 1.00% |
| Kingstown Capital | 599,998 | $5,052,000 | 0.50% |
| KNOTT DAVID M | 109,184 | $919,000 | 0.46% |
| Ancora Advisors LLC | 560,613 | $4,721,000 | 0.34% |